JournalsHub
.online
Find My Journal
MP

Marion Procter

Frontier Agriculture (United Kingdom) GB

54
Publications
12,367
Citations
21
H-Index
26
i10-Index
16.33
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

53 total

Abstract GS1-04: Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2-positive early breast cancer

Martine Piccart, Marion Procter, Debora Fumagalli, Evandro de Azambuja, Emma Clark et al. - Cancer Research, 2020
Cited by 34 OpenAlex

Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial PDF

Otto Metzger, Marion Procter, Evandro de Azambuja, Brian Leyland‐Jones, Richard D. Gelber et al. - Journal of Clinical Oncology, 2013
Cited by 45 OpenAlex

Hera Trial: 2 Years Versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with Her2-Positive Early Breast Cancer at 8 Years of Median Follow up

Aron Goldhirsch, Martine Piccart, Marion Procter, Evandro de Azambuja, H. Wéber et al. - Annals of Oncology, 2012
Cited by 29 OpenAlex

Research Topics

HER2/EGFR in Cancer Research (43) Breast Cancer Treatment Studies (24) Peptidase Inhibition and Analysis (17) Monoclonal and Polyclonal Antibodies Research (12) Cancer Treatment and Pharmacology (11)

Affiliations

Roche (Switzerland)
CH 2018 - 2011
Université Libre de Bruxelles
BE 2015 - 2011
Institute of Cancer Research
GB 2016 - 2011
Emory University
US 2011 - 2011
National and Kapodistrian University of Athens
GR 2010 - 2010

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now